-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AjsawLPx7TyNsgcVZIz8SxiwiphEwhW/DyE38l5HuDIwa2O5d2nrork7RDxh8M6l KSiXqj4wcu2GzBgfIr26Dg== 0001225208-10-010112.txt : 20100407 0001225208-10-010112.hdr.sgml : 20100407 20100407161927 ACCESSION NUMBER: 0001225208-10-010112 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100401 FILED AS OF DATE: 20100407 DATE AS OF CHANGE: 20100407 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANKLER DOUGLAS M CENTRAL INDEX KEY: 0001488270 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 10737209 MAIL ADDRESS: STREET 1: PFIZER INC. ATTN: CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 3 1 doc3.xml X0203 3 2010-04-01 0 0000078003 PFIZER INC PFE 0001488270 LANKLER DOUGLAS M PFIZER INC. ATT: CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 1 Senior Vice President Common Stock 80703 D Common Stock 900 I By Rule 16b-3 Plan Employee Stock Option (right to buy) 25.87 2010-02-22 2017-02-21 Common Stock 25400 D Employee Stock Option (right to buy) 26.2 2008-02-24 2015-02-23 Common Stock 13800 D Employee Stock Option (right to buy) 26.2 2009-02-23 2016-02-22 Common Stock 21700 D Employee Stock Option (right to buy) 29.33 2006-02-27 2013-02-26 Common Stock 15000 D Employee Stock Option (right to buy) 37.15 2007-02-26 2014-02-25 Common Stock 35000 D Employee Stock Option (right to buy) 41.3 2005-02-28 2012-02-27 Common Stock 9700 D Employee Stock Option (right to buy) 45.34 2011-02-21 Common Stock 9000 D Phantom Stock Units SSP Common Stock 4063 D Stock Appreciation Rights 12.7 2014-02-26 2014-02-26 Common Stock 23818 D Stock Appreciation Rights 17.69 2015-02-25 2015-02-25 Common Stock 32855 D Stock Appreciation Rights 18.19 2014-12-31 2014-12-31 Common Stock 21413 D Stock Appreciation Rights 22.55 2013-02-28 2013-02-28 Common Stock 12200 D The options became exercisable in three annual installments beginning on February 22, 2002. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Each unit represents one phantom share of common stock. The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. poadl10.HTM Lawrence A. Fox, by power of atty., for Douglas M. Lankler 2010-04-07 EX-24 2 poadl10.htm Untitled Document

POWER OF ATTORNEY

 

The undersigned hereby constitutes and appoints each of Gene A. Capello, Lawrence A. Fox, Tara J. Gabbai, Claire G. Keyles, Robert B Lamm and Matthew Lepore as the undersigned’s true and lawful attorney-in-fact and agent, and grants each of them full power to act on behalf of the undersigned and in the undersigned’s name, place and stead, in any and all capacities, for the purpose of completing and signing, on behalf of the undersigned,

  • any Form 3, Form 4 or Form 5 required or permitted to be filed by the undersigned pursuant to Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
  • any Form 144 required to be filed by the undersigned under the Securities Act of 1933, as amended (the “Securities Act”), and Rule 144 promulgated thereunder, and
  • any and all other documents, including, without limitation, Form ID, necessary or desirable to facilitate the filing by the undersigned of Form 144 and forms under Section 16 of the Exchange Act,  

with regard to the undersigned's ownership of or transactions in securities of Pfizer Inc., including, without limitation, the power to complete and sign any and all amendments to such forms and documents, if any, and to file such forms and documents and amendments thereto with the Securities and Exchange Commission, and to do and perform each and every act and thing requisite or necessary to be done in connection with such forms and documents, as fully and to all intents and purposes as the undersigned might or could do in person. 

The authority of Gene A. Capello, Lawrence A. Fox, Tara J. Gabbai, Claire G. Keyles, Robert B. Lamm and Matthew Lepore under this Power of Attorney shall continue until the undersigned is no longer required to file Form 3, Form 4, Form 5 or Form 144 with regard to the undersigned's ownership of or transactions in securities of Pfizer Inc., unless earlier revoked in writing.  The undersigned acknowledges that Gene A. Capello, Lawrence A. Fox, Tara J. Gabbai, Claire G. Keyles, Robert B. Lamm and Matthew Lepore are not assuming any of the undersigned's responsibilities to comply with Rule 144 under the Securities Act or Section 16 of the Exchange Act.

 

Signature: /s/ Douglas M. Lankler
                   Douglas M. Lankler

Date: March 30, 2010

 -----END PRIVACY-ENHANCED MESSAGE-----